We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+35.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$179M
AUM Growth
-$219M
Cap. Flow
-$249M
Cap. Flow %
-138.94%
Top 10 Hldgs %
17.69%
Holding
1,341
New
343
Increased
62
Reduced
166
Closed
769

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 16.1%
2 Technology 14.59%
3 Industrials 13.7%
4 Financials 11.48%
5 Communication Services 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDB icon
551
Solid Biosciences
SLDB
$900M
$31K 0.02%
695
-639
-48% -$26.5K
ENZ
552
DELISTED
Enzo Biochem, Inc.
ENZ
$31K 0.02%
+13,911
New +$35.8K
AAIC
553
DELISTED
Arlington Asset Investment Corp.
AAIC
$31K 0.02%
+10,478
New +$28K
TLPH icon
554
Talphera
TLPH
$74.2M
$29K 0.02%
1,179
-4,543
-79% -$127K
XCUR icon
555
Exicure
XCUR
$8.54M
$29K 0.02%
+78
New +$28.3K
SNGX icon
556
Soligenix
SNGX
$5.81M
$24K 0.01%
+48
New +$19.8K
BGG
557
DELISTED
Briggs & Stratton Corp.
BGG
$24K 0.01%
18,337
-1,833
-9% -$3.36K
CSLT
558
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$21K 0.01%
+25,159
New +$18.7K
MUX icon
559
McEwen Inc
MUX
$1.18B
$20K 0.01%
2,028
-3,215
-61% -$29.9K
VSTM icon
560
Verastem
VSTM
$610M
$18K 0.01%
+882
New +$23.3K
CCO icon
561
Clear Channel Outdoor Holdings
CCO
$1.23B
$17K 0.01%
+16,261
New +$15.3K
GEN
562
DELISTED
Genesis Healthcare, Inc.
GEN
$16K 0.01%
+22,972
New +$18.5K
MTNB icon
563
Matinas BioPharma
MTNB
$1.81M
$15K 0.01%
+384
New +$14.7K
TNXP icon
564
Tonix Pharmaceuticals
TNXP
$192M
0
CPE
565
DELISTED
Callon Petroleum Company
CPE
$14K 0.01%
1,246
-51,827
-98% -$459K
LCTX icon
566
Lineage Cell Therapeutics
LCTX
$278M
$13K 0.01%
+15,191
New +$13.4K
RRD
567
DELISTED
RR Donnelley & Sons Co.
RRD
$13K 0.01%
+10,768
New +$13.1K
HPR
568
DELISTED
HighPoint Resources Corporation
HPR
$11K 0.01%
+723
New +$10.5K
GSM icon
569
FerroAtlántica
GSM
$839M
$9K 0.01%
+18,600
New +$11.1K
ONIT
570
Onity Group
ONIT
$332M
$8K ﹤0.01%
+773
New +$6.64K
DNR
571
DELISTED
Denbury Resources, Inc.
DNR
$4K ﹤0.01%
14,447
-301,597
-95% -$90.6K
AXAS
572
DELISTED
Abraxas Petroleum Corp
AXAS
$3K ﹤0.01%
+722
New +$3.27K
AA icon
573
Alcoa
AA
$13.2B
-27,942
Closed -$172K
AAP icon
574
Advance Auto Parts
AAP
$3.49B
-3,290
Closed -$307K
ABBV icon
575
AbbVie
ABBV
$435B
-5,122
Closed -$390K

Similar funds

GSA Capital Partners's Q2 2020 Portfolio in Review

As of Q2 2020, GSA Capital Partners held 1,341 positions worth $179M, down 55% from $399M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

GSA Capital Partners withdrew a net $249M in Q2 2020, closing 769 positions and reducing 166 holdings. Its most notable exit was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $26M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, GSA Capital Partners opened a new position in Nebius Group N.V. worth $7.34M.

  • GSA Capital Partners's largest Q2 2020 buy was Nebius Group N.V.: 146,789 shares worth $7.34M.
  • GSA Capital Partners added most to Micron Technology in Q2 2020, an estimated $1.56M increase.
  • GSA Capital Partners's biggest Q2 2020 reduction was State Street SPDR Bloomberg High Yield Bond ETF, cutting an estimated $26.9M.
  • GSA Capital Partners fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2020, selling an estimated $26M.
  • GSA Capital Partners's ten largest holdings make up 18% of its $179M portfolio in Q2 2020.
  • GSA Capital Partners opened 343 new positions and closed 769 in Q2 2020.
  • GSA Capital Partners's portfolio value fell 55% quarter-over-quarter to $179M.

Based on GSA Capital Partners's 13F filing for Q2 2020, filed 11 Aug 2020.